[Hwa Guang] Announcement of the Scheduled Board Meeting Date for the Q2 2026 Financial Report
Hwa Guang announced that the board meeting to review the Q2 2026 financial report is scheduled for A… · 2026-08-03
華廣 News Releases
Huakwang Announces Its Continuous Glucose Monitoring System (CGM) Receives EU MDR Certification
Huakwang Biotechnology Co., Ltd. has announced that its self-developed Continuous Glucose Monitoring… · 2026-07-10
Bionime Announces Board Approval of Q1 2026 Consolidated Financial Report
Bionime Corporation announced on May 13, 2026, the board's approval of its Q1 2026 consolidated fina… · 2026-05-13
Bionime Announces Board Approval of Q1 2026 Consolidated Financial Report
Bionime Corporation announced on May 13, 2026, the board's approval of its Q1 2026 consolidated fina… · 2026-05-13
Hwa Guang Announces Shareholders' Approval to Lift Non-Competition Restriction for Director Fan Pu
On June 26, 2026, Hwa Guang's annual shareholders' meeting approved the lifting of non-competition r… · 2026-06-26
[Hwa Guang] Announcement of Important Resolutions from the 115th Annual Shareholders' Meeting
Hwa Guang held its annual shareholders' meeting on June 26, 2026, approving the loss allocation for … · 2026-06-26
[Huagung] February 2026 Revenue NT$111 Million (YoY -28.9%)
Huagung (stock code: 4737) announced its revenue report for February 2026. The revenue for the month… · 2026-02-01
[Bionime Corp.] March 2026 Revenue NT$167M (YoY +4.7%)
Bionime Corp. announced its monthly revenue for March 2026 was NT$167 million, a 4.7% increase year-… · 2026-03-01
[Bionime] May 2026 Revenue Reaches NT$142 Million (YoY -13.5%)
Bionime announced its monthly revenue for May 2026, reaching NT$141.7 million, down 13.5% compared t… · 2026-05-01
【Huaguang】April 2026 Revenue 141 Million (YoY -8.4%)
Huaguang announced its April 2026 monthly revenue of 141 million yuan, a decrease of 8.4% year-on-ye… · 2026-04-01
Huagung: Announcement of the Board Meeting Date for Q1 2026 Financial Report on May 13, 2026
Huagung announced on May 5, 2026, that a board meeting to discuss its Q1 2026 financial report is sc… · 2026-05-13
【Bionime】Announcement: Company's "RIGHTEST iFree2 Continuous Glucose Monitoring System (CGM)" Obtains Class II Medical Device Approval Notice from Taiwan Food and Drug Administration (TFDA)
Bionime Corporation announced that its second-generation continuous glucose monitoring system, "RIGH… · 2026-04-29
[Bionime Corp.] March 2026 Revenue NT$167M (YoY +4.7%)
Bionime Corp. announced its monthly revenue for March 2026 was NT$167 million, a 4.7% increase year-… · 2026-03-01
[Huagung] February 2026 Revenue NT$111 Million (YoY -28.9%)
Huagung (stock code: 4737) announced its revenue report for February 2026. The revenue for the month… · 2026-02-01
【Huaguang】April 2026 Revenue 141 Million (YoY -8.4%)
Huaguang announced its April 2026 monthly revenue of 141 million yuan, a decrease of 8.4% year-on-ye… · 2026-04-01
Huagung: Announcement of the Board Meeting Date for Q1 2026 Financial Report on May 13, 2026
Huagung announced on May 5, 2026, that a board meeting to discuss its Q1 2026 financial report is sc… · 2026-05-13
【Bionime】Announcement: Company's "RIGHTEST iFree2 Continuous Glucose Monitoring System (CGM)" Obtains Class II Medical Device Approval Notice from Taiwan Food and Drug Administration (TFDA)
Bionime Corporation announced that its second-generation continuous glucose monitoring system, "RIGH… · 2026-04-29